NCT02135601

Brief Summary

Water exchange method has been shown to reduce medication requirement and pain experienced during colonoscopy. It may increase the adenoma detection rate (ADR). Water exchange provides salvage cleansing and the refractive index of water (n equals about 1.3) is larger than that of air, which creates optical distortion that likely contributes to objects appearing larger underwater, making smaller lesions easier to visualize and it may help draw attention to those smaller lesions during withdraw. These principles facilitate to the higher adenoma detection rate. There is a large number of literature on the adenoma detection rate during water exchange colonoscopy, but most studies have been conducted in only one centre, simple-size, and under sedation patients, the influence of adenoma detection rate under unsedation patients was unclear. The aim of this study is to compare the ADR of colonoscopy by using the water exchange method versus the conventional air method in unsedation patients in multiple centers in China.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,303

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2014

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 8, 2014

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 12, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2015

Completed
Last Updated

November 10, 2015

Status Verified

August 1, 2015

Enrollment Period

1.2 years

First QC Date

May 8, 2014

Last Update Submit

November 8, 2015

Conditions

Keywords

colonoscopywateradenomapain

Outcome Measures

Primary Outcomes (1)

  • Adenoma detection rate

    The proportion of participants with at least one adenoma in each group

    up to one year

Secondary Outcomes (4)

  • Pain Scores on the Visual Analog Scale

    up to one year

  • Cecal intubation success rate

    up to one year

  • Cecum intubation time

    up to one year

  • Quality of Bowel Preparation

    up to one year

Study Arms (2)

Air colonoscopy

NO INTERVENTION

Colonoscopy will be performed without medications and with judicious air insufflation during colonoscope insertion.

Water colonoscopy

OTHER

Colonoscopy will be performed without medications and aided by water infusion in-lieu of air insufflation during insertion of the colonoscope.

Other: Water colonoscopy

Interventions

Colonoscopy will be performed without medications and aided by water infusion in-lieu of air insufflation during insertion of the colonoscope. The water infusion involves putting warm sterile water into the colon to open up the colon for advancement of the colonoscope until the end of the colon (cecum) is reached. The water is delivered through scope irrigation channel by an infusion pump equipped with a foot switch which will be controlled by the endoscopist. Infused water used to cleanse residual fecal matter will be suctioned as needed to clear the colonic lumen.

Water colonoscopy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18-80 patients with intact colon and rectum

You may not qualify if:

  • prior finding of severe colorectal stricture;
  • solid fetus contained in the last stool before colonoscopy
  • no bowel preparation or cleansed by enema/lavage
  • without the requirement of reaching cecum
  • known colorectal polyps or polyposis syndrome without complete removal previously
  • pregnant women
  • hemodynamically unstable
  • patients who cannot give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Chaoyang Hospital

Beijing, Beijing Municipality, 100020, China

Location

General Hospital of Guangzhou Military Command

Guangzhou, Guangdong, 510010, China

Location

Union Hospital of Tongji Medical college

Wuhan, Hubei, 430022, China

Location

Xijing Hospital of Digestive Diseases

Xi'an, Shaanxi, 710032, China

Location

Renji Hospital

Shanghai, Shanghai Municipality, 200000, China

Location

First Teaching Hospital of Xinjiang Medical University

Ürümqi, Xinjiang, 830054, China

Location

MeSH Terms

Conditions

AdenomaPain

Condition Hierarchy (Ancestors)

Neoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Yanglin Pan, M.D.

    Air Force Military Medical University, China

    PRINCIPAL INVESTIGATOR
  • Felix W. Leung, M.D.

    Sepulveda Ambulatory Care Center, VAGLAHS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associated professor

Study Record Dates

First Submitted

May 8, 2014

First Posted

May 12, 2014

Study Start

April 1, 2014

Primary Completion

July 1, 2015

Study Completion

July 1, 2015

Last Updated

November 10, 2015

Record last verified: 2015-08

Locations